Washington, November 10: The US Food and Drug Administration (FDA) has approved the world’s first chikungunya vaccine. The vaccine Ixchiq, developed by French biotech company Valneva, is approved for individuals 18 years of age and older, who are at increased risk of exposure to chikungunya virus. Ixchiq is administered as…Read More
USFDA Approves Worlds First Chikungunya Vaccine Ixchitq Developed by French Biotech Company Valneva LatestLY
